Shimadzu Releases GCMS-TQ8040 Triple Quadrupole Gas Chromatograph Mass Spectrometer
May 20, 2014
Shimadzu's new GCMS-TQ8040 inherits the performance of the GCMS-TQ8030 triple quadrupole gas chromatograph mass spectrometer (GCMS), which provides ppt (1 trillionth) level sensitivity and ultra-high-speed analysis. At the same time, the GCMS-TQ8040 offers significantly improved throughput and operability. This product features excellent productivity via simultaneous analysis, smart operability, high sensitivity, and high speed. In addition, [...]
Bioo Scientific Offers State-of the-Art, Full Service Analytical Food Testing
May 20, 2014
Bioo Scientific’s Lab Testing Group offers full service testing for contaminants in complex food matrices using state-of-the-art laboratory facilities and analytical testing methods, including high pressure liquid chromatography (HPLC) analysis and ELISA. Bioo Scientific’s Lab Services offer competitive pricing, with rapid turnaround times and reliable, reproducible results and a level of support that’s second to [...]
Soil contamination detector launched in the US
May 20, 2014
The device, RemScan, developed by CSIRO and industry partner Ziltek, uses an infrared signal to directly measure petroleum hydrocarbons in the soil, giving a result in around 20 seconds. The ability to rapidly and accurately detect petroleum contamination on site, instead of the traditional method of sending soil samples to a laboratory and waiting days [...]
Stomacher® plays key role in USDA protocols extracting contamination free antigen samples
May 20, 2014
Worthing, UK –– Seward Ltd., manufacturer of the world leading range of original Stomacher® paddle blenders and accessories used in sample preparation for microbiological analysis, confirms the use of its Stomacher® in USDA meat speciation protocols [1]. Following recent high profile meat provenance scandals, Seward has noted an increase in enquiries on the application of [...]
Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
May 20, 2014
Hercules, CA — — Bio-Rad Laboratories, Inc. announces an expansion of its line of PrimePCR probe assays for Droplet Digital PCR that adds another 56 assays for mutation detection and 109 assays for copy number variation (CNV) analysis to Bio-Rad’s catalog of existing assays for use on its QX100™ and QX200™ Droplet Digital PCR systems. [...]
Microsoft and BD Launch Accelerator in Israel for Healthcare Startups
May 20, 2014
TEL AVIV, Israel — — For the first time in the Israeli market, two major corporations will cooperate to help identify potential breakthrough startups. Microsoft and BD (Becton, Dickinson and Company), a leading global medical technology company, are working together to establish a unique accelerator experience for startups creating advancements for the healthcare industry. The [...]
May 20, 2014
San Diego, CA -– Daylight Solutions, Inc., a leading manufacturer of molecular detection and imaging solutions in the mid-infrared, today announced delivery of the world’s first commercially available laser-based infrared microscopy platform. The company’s advanced microscope was delivered to Dr. Rebekah Drezek’s Optical Molecular Imaging and Nanobiotechnology Laboratory at Rice University in Houston, Texas. The [...]
May 20, 2014
Cambridge Research Biochemicals (CRB), offering expertise in the custom supply of research reagents, principally peptides and antibodies, has once again demonstrated customer satisfaction with the extension of an important contract in the medical research field. CRB, based in the North East of England in Billingham on Teesside, has announced renewal of its contract with UK [...]
New Parvovirus B19 Monoclonal Antibody
May 20, 2014
Parvovirus B19 is a small non-enveloped DNA virus. It is the cause of “fifth disease” so named for being one of the 5 childhood diseases at the time to cause a rash. It’s transmission is via aerosols and infection is usually self limiting. 50% of all adults exhibit a seropositive history for this virus. However [...]
N-of-One Selected by Guardant Health to Provide Clinical Interpretation for Guardant360™ Tests
May 19, 2014
LEXINGTON, Mass.-– N-of-One, the leader in clinical interpretation for precision medicine in oncology, today announced an agreement with Guardant Health to provide clinical decision support for Guardant360™, a breakthrough blood test that enables next generation sequencing of solid tumor DNA. Financial terms of the agreement are not disclosed. Guardant360 is the first pan-cancer blood test [...]
